Growth Investment Partners (GIP) Ghana Ltd, an investment vehicle created by British International Investment (BII), is channeling fresh capital into mPharma Ghana Ltd to deepen access to affordable medicines and improve healthcare delivery across West Africa.
The funding will allow mPharma to strengthen its inventory management system and expand its pharmacy franchise network across Ghana, Togo, and Benin.
The initiative is part of a broader plan to consolidate the company’s presence in Francophone West Africa, where growing demand for affordable pharmaceutical services presents an opportunity for scale.
The Chief Executive Officer (CEO) of mPharma, Kwesi Arhin, said the investment will help the company deepen its partnerships with pharmacies and healthcare providers across the region.
“Our goal is to ensure equitable access to quality medicines and timely healthcare services for all,” he said, adding that GIP’s support reinforces mPharma’s ability to expand its regional footprint and sustain affordable pricing.
Impact
The investment is expected to boost mPharma’s Vendor Managed Inventory (VMI) system, which pools demand across its network of pharmacies to negotiate better prices with suppliers.
By optimising procurement and reducing wastage, the system helps stabilise medicine prices and ensures consistent availability of essential drugs, particularly in low-income communities.
Founded in 2013, mPharma operates a growing network of community pharmacies under the multi brand, providing patients with access to licensed doctors, diagnostic services, and affordable medicines.
The company’s technology-driven approach, built around its proprietary Bloom software and AWS-powered analytics infrastructure, enables real-time monitoring of stock levels and predictive forecasting to prevent shortages.
mPharma’s expansion is expected to extend its reach to millions of new patients over the next five years, with plans to roll out additional disease management programmes beyond diabetes.
The company is scaling its Diabetes Test & Treat model to include hypertension care—a leading health concern in the region—and exploring further integration of data-driven health interventions across its network.
For local pharmacy owners, joining mPharma’s multi franchise offers access to upgraded infrastructure, working capital, management support, and technology systems that improve profitability and efficiency.
The model also supports job creation by strengthening locally owned healthcare enterprises and expanding professional opportunities across the value chain.
Commitment
The CEO of GIP Ghana, Jacob Kholi, said the partnership underscores GIP’s commitment to backing impactful enterprises that deliver essential services while creating sustainable economic value.
He noted that mPharma’s expansion will “enable more communities to access affordable healthcare” and enhance the resilience of local health systems.
mPharma’s impact has grown steadily in recent years. Its mutti membership programme has expanded from under 10,000 members in 2019 to more than 400,000 at the end of 2024.
More than 70 per cent of members report lower drug prices, while over three-quarters experience uninterrupted access to essential medicines.
As the partnership scales, both GIP and mPharma aim to achieve measurable reductions in drug prices, expand diagnostic and chronic disease services, and reinforce regional supply chains.
The broader goal, according to the partners, is to build a sustainable, technology-enabled healthcare ecosystem that improves health outcomes while supporting inclusive economic growth across West Africa.